Submitted by Anonymous (not verified) on 19 August 2026 - 15:30
Human medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Revision: 1, Status: Authorised